Supplemental material
Leukemia & Lymphoma
Volume 57, 2016 - Issue 1
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes.
Source:
American Society of Hematology
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders.
Source:
Frontiers Media SA
Myelodysplastic syndromes current treatment algorithm 2018.
Source:
Springer Science and Business Media LLC
A Feasibility Study of Designing a Family-Caregiver-Centred Dementia Care Handbook
Source:
Springer International Publishing
End-of-Life Care for MDS
Source:
Wiley
Linking provided by
